Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026

Rhea-AI Summary

Jazz Pharmaceuticals (Nasdaq: JAZZ) announced it will report its 2026 second quarter financial results on Monday, August 3, 2026, after the close of U.S. financial markets. Company management will host a webcast at 4:30 p.m. ET to review results and provide a business and financial update.

Interested participants can register via the Investors section of the Jazz Pharmaceuticals website and are encouraged to do so at least 15 minutes before the webcast. A replay will be available on the same site. Jazz describes itself as a global biopharma company focused on medicines for rare diseases, epilepsies, cancers and sleep disorders.

News Market Reaction – JAZZ

+4.42%

3 alerts

+4.42% Session close to close

$15.55B Market Cap

0.6x Rel. Volume

In the Jul 21 session, JAZZ gained 4.42%, reflecting a moderate positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Prior tag-matched announcements produced +0.84% and +0.37% reactions, adding historical context to t...

Analysis

Prior tag-matched announcements produced +0.84% and +0.37% reactions, adding historical context to this scheduling notice. Low short positioning and Net Selling insider activity were relevant factors to monitor.

Key Figures

Reporting period: 2026 second quarter Report date: August 3, 2026 Webcast time: 4:30 p.m. ET +1 more

4 metrics

Reporting period 2026 second quarter Scheduled financial results

Report date August 3, 2026 After the close of U.S. financial markets

Webcast time 4:30 p.m. ET Management discussion of results and business update

Registration lead time 15 minutes Recommended advance registration before the webcast

Previous Earnings date Reports

2 past events · Latest: Apr 21 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 21	Earnings date	Neutral	+0.8%	Scheduled first-quarter results and webcast after the U.S. market close
Feb 10	Earnings date	Neutral	+0.4%	Scheduled fourth-quarter and full-year results with webcast after U.S. market close

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Both prior tag-matched earnings-date announcements were followed by positive 24-hour reactions of +0.84% and +0.37%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DUBLIN, July 20, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced it will report its 2026 second quarter financial results on Monday, August 3, 2026, after the close of the U.S. financial markets. Company management will host a webcast at 4:30 p.m. ET to discuss the results and provide a business and financial update.  

Interested parties may register for the call in advance here or via the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast.

A replay of the webcast will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations.

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.

Contacts:

Investors:
InvestorInfo@jazzpharma.com
Ireland +353 1 634 3211
U.S. +1 650 496 2717

Media:
CorporateAffairsMediaInfo@jazzpharma.com
Ireland +353 1 637 2141
U.S. +1 215 867 4948

View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-report-second-quarter-financial-results-on-august-3-2026-302829867.html

SOURCE Jazz Pharmaceuticals plc

FAQ

When will Jazz Pharmaceuticals (JAZZ) report its Q2 2026 financial results?

Jazz Pharmaceuticals plans to report its Q2 2026 financial results on Monday, August 3, 2026, after U.S. market close. According to Jazz Pharmaceuticals, management will discuss the results during a webcast scheduled for 4:30 p.m. Eastern Time on the same day.

What time is the Jazz Pharmaceuticals (JAZZ) Q2 2026 earnings webcast on August 3, 2026?

The Jazz Pharmaceuticals Q2 2026 earnings webcast is scheduled for 4:30 p.m. ET on August 3, 2026. According to Jazz Pharmaceuticals, the webcast will cover the quarterly results and include a broader business and financial update for investors.

How can investors access the Jazz Pharmaceuticals (JAZZ) Q2 2026 earnings call webcast?

Investors can access the Jazz Pharmaceuticals Q2 2026 earnings webcast via the Investors section of the company’s website. According to Jazz Pharmaceuticals, interested parties should register online and are advised to complete registration at least 15 minutes before the scheduled start.

Will there be a replay of the Jazz Pharmaceuticals (JAZZ) Q2 2026 earnings webcast?

Yes, a replay of the Jazz Pharmaceuticals Q2 2026 earnings webcast will be available online. According to Jazz Pharmaceuticals, investors can access the replay through the Investors section of its website under events and presentations after the live event concludes.

What type of business update will Jazz Pharmaceuticals (JAZZ) provide with its Q2 2026 results?

Jazz Pharmaceuticals will provide both a business and financial update alongside Q2 2026 results. According to Jazz Pharmaceuticals, company management will use the August 3, 2026 webcast to discuss quarterly performance and broader business developments with the investment community.

Where is Jazz Pharmaceuticals (JAZZ) headquartered and what is its business focus?

Jazz Pharmaceuticals is headquartered in Dublin, Ireland and operates as a global biopharma company. According to Jazz Pharmaceuticals, it focuses on developing life-changing medicines for rare diseases, including therapies addressing epilepsies, cancers and sleep disorders across a diverse commercial portfolio.